Pathogen adaptation under imperfect vaccination: Implications for pertussis

Proceedings of the Royal Society B: Biological Sciences

Volumn 272, Issue 1572, 2005, Pages 1617-1624

  Van Boven, Michiel ^a   Mooi, Frits R ^b,c   Schellekens, Joop F P ^c   De Melker, Hester E ^c   Kretzschmar, Mirjam ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Adaptive dynamics; Bordetella; Evolutionary stability; Virulence

Indexed keywords

ADAPTATION; EVOLUTION; PATHOGEN; VACCINATION;

ADAPTIVE BEHAVIOR; ARTICLE; IMMUNITY; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; PERTUSSIS; PRIORITY JOURNAL; VACCINATION;

BORDETELLA;

EID: 26244442830     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2005.3108     Document Type: Article

References (45)

1. Birkebaek, N. H., Kristiansen, M., Seefeldt, T., Degn, J., Moller, A., Heron, I., Andersen, P. L., Moller, J. K. & Ostergard, L. 1999 Bordetella pertussis and chronic cough in adults. Clin. Infect. Dis. 29, 1239-1242.
2. Casadevall, A. & Pirofsky, L. 1999 Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 67, 3701-3713.
3. Cassiday, P., Sanden, G., Heuvelman, K., Mooi, F., Bisgard, K. M. & Popovic, T. 2000 Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J. Infect. Dis. 182, 1402-1408.
4. Cohen, M. L. 2000 Changing patterns of infectious disease. Nature 406, 762-767.
5. Cotter, P. A. & DiRita, V. J. 2000 Bacterial virulence gene regulation: an evolutionary perspective. Annu. Rev. Microbiol. 54, 519-565.
6. Cotter, P. A. & Miller, J. F. 2000 Genetic analysis of the Bordetella infectious cycle. Immunopharmacology 48, 253-255.
7. Day, T. & Burns, J. G. 2003 A consideration of patterns of virulence arising from host-parasite coevolution. Evolution 57, 671-676.
8. de Melker, H. E., Schellekens, J. F., Neppelenbroek, S. E., Mooi, F. R., Rumke, H. C. & Conyn-van Spaendonck, M. A. 2000 Reemergence of pertussis in the highly vaccinated population of The Netherlands: observations on surveillance data. Emerging Infect. Dis. 6, 348-357.
9. Dieckmann, U. 2002 Adaptive dynamics of pathogen-host interactions. In Pursuit of virulence management: adaptive dynamics of infectious diseases (ed. U. Dieckmann et al.), pp. 39-59. Cambridge: Cambridge University Press.
10. Diekmann, O. & Heesterbeek, J. A. P. 2000 Mathematical epidemiology of infectious diseases. Model building, analysis and interpretation. New York: Wiley.
11. Gandon, S., Mackinnon, M. J., Nee, S. & Read, A. F. 2001 Imperfect vaccines and the evolution of pathogen virulence. Nature 414, 751-756.
12. Gandon, S., Mackinnon, M., Nee, S. & Read, A. 2003 Imperfect vaccines: some epidemiological and evolutionary consequences. Proc. R. Soc. B 270, 1129-1136. (doi:10.1098/rspb.2003.2370.)
13. Gilberg, S., Njamkepo, E., Du Chatelet, I. P., Partouche, H., Gueirard, P., Ghasarossian, C., Schlumberger, M. & Guiso, N. 2002 Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J. Infect. Dis. 186, 415-418.
14. Gomes, M. G. M., Medley, G. F. & Nokes, D. J. 2002 On the determinants of population structure in antigenically diverse pathogens. Proc. R. Soc. B 269, 227-233. (doi:10.1098/rspb.2001.1869.)
15. Greenhalgh, D., Diekmann, O. & de Jong, M. C. 2000 Subcritical endemic steady states in mathematical models for animal infections with incomplete immunity. Math. Biosci. 165, 1-25.
16. Hethcote, H. W. & Li, Y. 1999 Hopf bifurcation in models for pertussis epidemiology. Math. Comput. Model. 30, 29-45.
17. Hijnen, M., Mooi, F. R., van Gageldonk, P. G., Hoogerhout, P., King, A. J. & Berbers, G. A. 2004 Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen. Infect. Immun. 72, 3716-3723.
18. Jefferson, T., Rudin, M. & DiPietrantonj, C. 2003 Systematic review of the effects of pertussis vaccines in children. Vaccine 21, 2003-2014.
19. King, A., Berbers, G., van Oirschot, H. F., Hoogerhout, P., Knipping, K. & Mooi, F. R. 2001 Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 147, 2885-2895.
20. May, R. M. & Anderson, R. M. 1983 Parasite-host coevolution. In Coevolution (ed. D. Futuyma & M. Slatkin), pp. 186-206. Sunderland, MA: Sinauer.
21. McLean, A. R. 1999 Development and use of vaccines against evolving pathogens: vaccine design. In Evolution in health and disease (ed. S. C. Stearns), pp. 138-151. Oxford: Oxford University Press.
22. McLean, A. R. 2002 Evolution of vaccine-resistant strains of infectious agents. In Pursuit of virulence management: adaptive dynamics of infectious diseases (ed. U. Dieckmann), pp. 339-361. Cambridge: Cambridge University Press.
23. Medley, G. F., Lindop, N. A., Edmunds, W. J. & Nokes, D. J. 2001 Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat. Med. 1, 619-624.
24. Metz, J. A., Nisbet, R. M. & Geritz, S. A. 1992 How should we define 'fitness' for general ecological scenarios? Trends Ecol. Evol. 7, 198-202.
25. Mink, C. M., Cherry, J. D., Christenson, P., Lewis, K., Pineda, E., Shlian, D., Dawson, J. A. & Blumberg, D. A. 1992 A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14, 447-464.
26. Mooi, F. R., van Oirschot, H., Heuvelman, K., van der Heide, H. G., Gaastra, W. & Willems, R. J. 1998 Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66, 670-675.
27. Mooi, F. R., He, Q., van Oirschot, H. & Mertsola, J. 1999 Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. 67, 3133-3134.
28. Mooi, F. R., van Loo, I. H. & King, A. J. 2001 Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerging Infect. Dis. 7, 526-528.
29. Nennig, M. E., Shinefield, H. R., Edwards, K. M., Black, S. B. & Fireman, B. H. 1996 Prevalence and incidence of adult pertussis in an urban population. JAMA 275, 1672-1674.
30. Parkhill, J. et al. 2003 Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35, 32-40.
31. Rohani, P., Earn, D. J. & Grenfell, B. T. 2000 Impact of vaccination on pertussis transmission in England and Wales. Lancet 355, 285-286.
32. Schmitt-Grohé, S., Cherry, J. D., Heininger, U., Uberall, M. A., Pineda, E. & Stehr, K. 1995 Pertussis in German adults. Clin. Infect. Dis. 21, 860-866.
33. Senzilet, L. D., Halperin, S.A., Spika, J. S., Alagaratnam, M., Morris, A. & Smith, B. 2001 Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin. Infect. Dis. 32, 1691-1697.
34. Smith, A. M., Guzman, C. A. & Walker, M. J. 2001 The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol. Rev. 25, 309-333.
35. Strebel, P., Nordin, J., Edwards, K., Hunt, J., Besser, J., Burns, S., Amundson, G., Baughman, A. & Wattigney, W 2001 Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J. Infect. Dis 183, 1353-1359.
36. Teunis, P. F., van der Heijden, O. G., de Melker, H. E., Schellekens, J. F., Versteegh, F. G. & Kretzschmar, M. E. 2002 Kinetics of IgG-antibody response to pertussis toxin after infection with B. pertussis. Epidemiol. Infect. 129, 479-489.
37. van Baalen, M. 1998 Coevolution of recovery ability and virulence. Proc. R. Soc. B 265, 317-325.
38. van Boven, M. & Weissing, F. J. 2004 The evolutionary economics of immunity. Am. Nat. 163, 277-294.
39. van Boven, M., de Melker, H. E., Schellekens, J. F. & Kretzschmar, M. 2000 Waning immunity and subclinical infection in an epidemic model: implications for pertussis in the Netherlands. Math. Biosci. 164, 161-182.
40. van Boven, M., Ferguson, N. M. & van Rie, A. 2004 Unveiling the burden of pertussis. Trends Microbiol. 12, 116-119.
41. van Loo, I. H., van der Heide, H. G., Nagelkerke, N. J., Verhoef, J. & Mooi, F. R. 1999 Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J. Infect. Dis. 179, 915-923.
42. van Loo, I. H. & Mooi, F. R. 2002 Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 148, 2011-2018.
43. von König, C. H., Halperin, S., Riffelmann, M. & Guiso, N. 2002 Pertussis of adults and infants. Lancet Infect. Dis. 2, 744-750.
44. Wright, S. W. 1995 Pertussis infections in adults with persistent cough. JAMA 273, 1044-1046.
45. Yuk, M. H., Harvill, E. T., Cotter, P. A. & Miller, J. F. 2000 Modulation of host immune responses, induction of apoptosis and inhibition of NF-κB activation by the Bordetella type III secretion system. Mol. Microbiol. 35, 991-1004.